FENC Fennec Pharmaceuticals Inc.

NASDAQ
$12.76

Fennec Pharmaceuticals Inc. (FENC) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal In line Selling ran in line with FENC's own trailing one-year pace, with 18% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 4 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
6
18 transactions
Purchases
$0
0 shares
Sales
$10.8M
1,337,963 shares
Net activity
-$10.8M
purchases less sales

How much of that selling was preplanned? 18% planned / 82% discretionary

10b5-1 plan sales $1.9M 10 transactions · 181,618 shares
Discretionary sales $8.9M 8 transactions · 1,156,345 shares

Largest single sale: $7.5M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Brughera Marco Maria Director Sell 10b5-1 20,000 $12.00 $240.0K None left
Brughera Marco Maria Director Sell 10b5-1 15,545 $10.29 $160.0K None left
Raykov Rosty Other Sell 10b5-1 10,000 $12.11 $121.1K 124,411 −7.4% of holding
Sayad Pierre Sargis Chief Medical Officer Sell 12,000 $12.18 $146.2K 9,519 −55.8% of holding
Andrade Robert CHIEF FINANCIAL OFFICER Sell 10b5-1 75,000 $11.78 $883.5K 217,675 −25.6% of holding
Raykov Rosty Other Sell 10b5-1 10,000 $9.58 $95.8K 131,633 −7.1% of holding
Raykov Rosty Other Sell 10b5-1 9,599 $10.41 $99.9K 138,855 −6.5% of holding
Raykov Rosty Director Sell 10b5-1 9,747 $9.62 $93.8K 130,079 −7% of holding
RALLIS CHRIS A Director Sell 8,346 $7.04 $58.8K 63,077 −11.7% of holding
Raykov Rosty Director Sell 10b5-1 10,781 $6.47 $69.8K 121,451 −8.2% of holding
Raykov Rosty Director Sell 10b5-1 10,946 $6.31 $69.1K 113,856 −8.8% of holding
Raykov Rosty Director Sell 10,079 $8.36 $84.3K 103,996 −8.8% of holding
Raykov Rosty Director Sell 10,349 $7.76 $80.3K 98,477 −9.5% of holding
Raykov Rosty Director Sell 10,312 $7.60 $78.4K 88,020 −10.5% of holding
Sell 1,000,000 $7.50 $7.5M 2,744,741 −26.7% of holding
Raykov Rosty Director Sell 10b5-1 10,000 $7.54 $75.4K 77,526 −11.4% of holding
Sell 19,341 $8.79 $170.0K 3,744,741 −0.5% of holding
Sell 85,918 $8.79 $755.2K 3,764,082 −2.2% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.